510(k) K253048
K253048 is an FDA 510(k) premarket notification submitted by Shenzhen Maiwei Biotech Co., Ltd. for the device "High Pressure Syringe; Pressure Connecting Tube; Quick fill tube; Spike; Transfer Tube". The FDA issued a decision of Substantially Equivalent on Apr 16, 2026. The device falls under product code DXT (Injector And Syringe, Angiographic), a Class II device regulated under 21 CFR 870.1650.
Clearance details
- Decision
- SESE (Substantially Equivalent)
- Decision Date
- Apr 16, 2026
- Date Received
- Sep 22, 2025
- Clearance Type
- Traditional
- Expedited Review
- No
- Third Party Review
- No
Device classification
- Device Name
- Injector And Syringe, Angiographic
- Device Class
- Class II
- Regulation Number
- 870.1650
- Review Panel
- HO
- Submission Type
- 510(k)
Need the full FDA record for Shenzhen Maiwei Biotech Co., Ltd.? Ask Claude or ChatGPT with the RegDataLab connector and get every site's inspections, Form 483s, warning letters, recalls and import alerts, each with a link to the FDA source. The API key is free: no card.